CHINARES PHARMA(03320): Liu Changan appointed as executive director.
China Resources Pharmaceutical Group (03320) announced that, starting from September 18, 2025, (1) Deng Rong resigned as an executive director...
CHINARES PHARMA (03320) issued an announcement that, as of September 18, 2025, (1) Deng Rong resigned as an executive director and member of the executive committee; and (2) Liu Changan was appointed as an executive director and member of the executive committee.
Related Articles
TIME WATCH (02033) issued a profit warning, anticipating an annual loss of HK$17 million for the company's shareholders compared to a profit.
Yu Cheng Kejin (00279) completes the placement of approximately 191 million shares.
Novo Nordisk A/S Sponsored ADR Class B (NVO.US) jumped in pre-market trading, Ozempic has better cardiovascular protective effects than traditional drugs like Lantus.
TIME WATCH (02033) issued a profit warning, anticipating an annual loss of HK$17 million for the company's shareholders compared to a profit.
Yu Cheng Kejin (00279) completes the placement of approximately 191 million shares.
Novo Nordisk A/S Sponsored ADR Class B (NVO.US) jumped in pre-market trading, Ozempic has better cardiovascular protective effects than traditional drugs like Lantus.
